Suomi - Farmaseuttiset tuotteet - Amivantamabi-injektionesteitä (Rybrevant® 1600 mg, 2240 mg, 2400 mg ja 3520 mg inj.neste) koskeva suorahankinta ajalle 1.9.2026-31.12.2027

Finland · Medical equipment & pharmaceuticals

different companies won awards here

414

of the awards went to the three most frequent winners

8%

buyers awarded contracts here

164

Based on 616 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

3.0

of those lots received a single tender

17%

of the awards went to companies based in another country

9%

of the tenders came from another country

2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.